Target intelligence / Profile preview

Aquaporin-3 channel (AQP3)

Target
AQP3
Molecular classification
Transporter, Channel protein, Major intrinsic protein family (MIP), Aquaglyceroporin (subclass of aquaporins)
01

Overview

Aquaporin-3 is an integral membrane water and glycerol channel belonging to the major intrinsic protein family. It forms homotetrameric complexes within the plasma membrane; each monomer independently mediates selective passage of water and small solutes such as glycerol across biological membranes along osmotic gradients. Unlike some other aquaporins that are strictly water-selective (“classic” AQPs), Aquaporin-3 is classified as an aquaglyceroporin, allowing both water and glycerol permeability. It is widely expressed—including kidney collecting ducts (basolateral membrane), skin keratinocytes, respiratory tract epithelium—and plays roles in fluid balance, epidermal hydration/barrier function, wound healing processes, energy metabolism via glycerol transport, and possibly oxidative stress response due to hydrogen peroxide permeability. Overexpression has been linked to tumor growth/metastasis; altered expression is associated with several dermatological disorders. Its unique dual selectivity makes it a potential therapeutic target for cancer treatment as well as certain inflammatory or metabolic diseases.

Other names
Aquaporin 3AQP-3Gill blood group proteinWater channel protein AQP-3
02

Mechanism of action

For drugs like SAHA: indirect upregulation of gene/protein expression via histone deacetylase inhibition. For hypothetical/experimental inhibitors: direct blockade of water/glycerol permeation through the channel pore.

03

Biological functions

Water transport across cell membranesGlycerol transport across cell membranesUrea, ammonia, and hydrogen peroxide transport
04

Disease associations

Cancer (overexpressed in various malignancies including melanoma, lymphomas, lung, colon, stomach, esophagus, mouth, liver and pancreatic duct cancers)Skin diseases (decreased in psoriasis; increased in atopic eczema)
05

Safety considerations

Potential safety concerns include disruption of normal water/glycerol homeostasis if inhibited systemically.Inhibition could affect skin hydration/barrier function or renal concentrating ability.Targeting may also impact immune responses or wound healing due to its role in epithelial tissues.
06

Interacting drugs

Suberoylanilide hydroxamic acid (SAHA)
07

Biomarkers

Aquaporin-3 expression levels can serve as a biomarker for certain skin conditions and cancers—lower levels are seen in psoriasis; higher levels are seen in atopic eczema and many tumors

Beyond the preview

Go deeper on Aquaporin-3 channel (AQP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aquaporin-3 channel (AQP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call